Director TitleAgeSince
Chairman - -
Chairman - 28/06/2012
Director/Board Member - 24/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
-0.18%+4.58%+3.88%+31.79% 47.86B
-0.83%-0.67%+42.61%+34.77% 44.46B
-0.84%+5.34%+8.05%+91.52% 41.85B
-1.10%-6.89%+329.50%+535.80% 41.34B
-0.62%-0.06%+10.15%+46.02% 30.04B
-2.07%-0.54%+23.90%+154.30% 17.59B
-6.08%-6.94% - - 15.6B
-3.55%+3.65%+21.51%+38.83% 15.69B
-0.78%+11.24%-10.81% - 13.93B
Average -1.38%+2.66%+53.60%+133.29% 29.82B
Weighted average by Cap. -1.11%+1.88%+67.06%+141.32%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock